ProPhase Labs Teams up with Certis Oncology to Accelerate Development of Novel Linebacker Compound
August 03, 2023 08:00 ET
|
ProPhase Labs, Inc.
Garden City, NY, Aug. 03, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next generation biotech, genomics, therapeutics and diagnostics company, today provided an...
ProPhase Labs to Present at the H.C. Wainwright 2022 Global Investment Conference
May 18, 2022 08:15 ET
|
ProPhase Labs, Inc.
May 23-26, 2022 (HYBRID CONFERENCE) Garden City, NY, May 18, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that...
ProPhase Labs Continues to Build Strong Leadership with Key Promotions and Additions to Management Team
December 16, 2021 08:30 ET
|
ProPhase Labs, Inc.
Precision Medicine division adds Industry Veteran Sam A. Beeler as Chief Strategy Officer; Diagnostics Division Promotes Alice Lioi and Jason Karkus to EVP and Co-Chief Operating Officers and Sergio...